Abeona Therapeutics Inc.
ABEO
$4.46
-$0.49-9.90%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 69.30% | -508.71% | 123.45% | -90.33% | -40.17% |
| Total Depreciation and Amortization | 7.48% | 5.40% | -5.39% | 0.42% | -3.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -124.05% | 175.32% | -221.38% | 240.44% | 88.84% |
| Change in Net Operating Assets | -2,055.06% | -107.27% | 186.90% | -377.54% | -57.05% |
| Cash from Operations | -35.35% | 3.55% | 12.75% | -57.42% | -60.72% |
| Capital Expenditure | -50.00% | 43.18% | 1.93% | -1,859.46% | 15.91% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | 112.50% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 438.05% | 86.73% | -512.51% | -161.41% | 161.74% |
| Cash from Investing | 406.08% | 86.03% | -464.56% | -167.80% | 161.51% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 1,048.48% | -17.58% | -66.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.44% | -2,035.71% | 98.57% | -206.27% | -7,875.00% |
| Cash from Financing | 1,877.26% | -100.41% | 189.64% | 240.70% | -67.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.81% | -210.86% | 446.77% | -68.39% | 745.14% |
